COHEN RAYMOND W — SEC insider filings

SEC reporting owner CIK 1258288. 27 insider filings on record with FilingPulse; latest filed 2026-10-01.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2020-08-11 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Axonics, Inc. (AXNX)Chief Executive Officer, Director16—33 legs · 502,501 sh · $29,891,01230
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Director52 legs · 27,000 sh · $488,8001 leg · 3,330 sh · $97,5043
BIOLIFE SOLUTIONS INC (BLFS)Director3—1 leg · 5,625 sh · $182,5312
RxSight, Inc. (RXST)Director2——2
InspireMD, Inc. (NSPR)Director1——1

Insider filings — COHEN RAYMOND W

FiledFormIssuerReported transactionsSource
2026-10-014KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Sale (S): 3,330 @ $29.28EDGAR
2026-09-104KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Grant/award (A): 7,217EDGAR
2026-06-184RxSight, Inc. (RXST)Grant/award (A): 30,864EDGAR
2026-03-304KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Purchase (P): 10,000 @ $19.98EDGAR
2026-01-164InspireMD, Inc. (NSPR)Grant/award (A): 44,030 @ $0EDGAR
2025-09-084KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Purchase (P): 17,000 @ $17 · Grant/award (A): 10,909EDGAR
2025-08-044RxSight, Inc. (RXST)Grant/award (A): 35,668 @ $0EDGAR
2025-07-244KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)Grant/award (A): 12,994EDGAR
2024-11-154Axonics, Inc. (AXNX)Disposition to issuer (D): 292,731 @ $71 · Disposition to issuer (D): 31,125 (derivative) @ $0 · Disposition to issuer (D): 196,451 (derivative) @ $56.81 · Disposition to issuer (D): 106,776 (derivative) @ $69.37EDGAR
2024-07-254Axonics, Inc. (AXNX)Option exercise (M): 25,771 @ $14.19 · Option exercise (M): 78,125 @ $25.82 · Option exercise (M): 78,125 (derivative) @ $0 · Option exercise (M): 25,771 (derivative) @ $0EDGAR
2024-02-024Axonics, Inc. (AXNX)Option exercise (M): 63,400 @ $0 · Sale (S): 35,161 @ $67.74 · Option exercise (M): 21,900 (derivative) @ $0 · Option exercise (M): 41,500 (derivative) @ $0EDGAR
2023-02-024Axonics, Inc. (AXNX)Grant/award (A): 20,750 @ $0 · Option exercise (M): 61,968 @ $0 · Sale (S): 13,872 @ $61.17 · Sale (S): 9,032 @ $61.12 · Sale (S): 1,185 @ $60.43 · Sale (S): 6,932 @ $61.02 · +4 moreEDGAR
2023-01-184Axonics, Inc. (AXNX)Sale (S): 18,684 @ $65.54 · Sale (S): 22,052 @ $66.27EDGAR
2022-08-104Axonics, Inc. (AXNX)Sale (S): 18,100 @ $69.50 · Sale (S): 12,092 @ $70.40 · Sale (S): 12,032 @ $71.65 · Sale (S): 1,776 @ $72.09EDGAR
2022-03-314Axonics, Inc. (AXNX)Sale (S): 50,000 @ $60EDGAR
2022-03-164Axonics, Inc. (AXNX)Sale (S): 17,787 @ $50.42 · Sale (S): 2,100 @ $51.40 · Sale (S): 1,981 @ $52.66 · Sale (S): 11,232 @ $53.95 · Sale (S): 16,900 @ $54.80EDGAR
2022-02-034Axonics, Inc. (AXNX)Grant/award (A): 43,297 @ $0 · Option exercise (M): 96,846 @ $0 · Sale (S): 33,336 @ $48.21 · Sale (S): 1,779 @ $49.03 · Grant/award (A): 21,968 (derivative) @ $0 · Grant/award (A): 10,950 (derivative) @ $0 · +2 moreEDGAR
2021-09-134Axonics, Inc. (AXNX)Sale (S): 50,000 @ $77.11EDGAR
2021-07-144BIOLIFE SOLUTIONS INC (BLFS)Grant/award (A): 5,000EDGAR
2021-06-104Axonics, Inc. (AXNX)Sale (S): 33,333 @ $60EDGAR
2021-05-204Axonics, Inc. (AXNX)Sale (S): 32,833 @ $55EDGAR
2021-05-124Axonics, Inc. (AXNX)Sale (S): 13,109 @ $52.98 · Sale (S): 17,954 @ $54.13 · Sale (S): 2,770 @ $54.81EDGAR
2021-02-024Axonics Modulation Technologies, Inc. (AXNX)Grant/award (A): 20,000 @ $0 · Option exercise (M): 33,334 @ $0 · Sale (S): 12,675 @ $51.36 · Sale (S): 952 @ $52.12 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 42,500 (derivative) @ $0 · +1 moreEDGAR
2021-01-274Axonics Modulation Technologies, Inc. (AXNX)Option exercise (M): 27,173 @ $0 · Sale (S): 7,842 @ $53.58 · Option exercise (M): 27,173 (derivative) @ $0EDGAR
2020-11-164BIOLIFE SOLUTIONS INC (BLFS)Sale (S): 5,625 @ $32.45EDGAR
2020-10-074BIOLIFE SOLUTIONS INC (BLFS)Grant/award (A): 5,000EDGAR
2020-08-114Axonics Modulation Technologies, Inc. (AXNX)Sale (S): 16,633 @ $41.82 · Sale (S): 3,367 @ $42.75 · Sale (S): 5,159 @ $40.95 · Sale (S): 8,808 @ $42.05 · Sale (S): 11,033 @ $42.78EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1258288 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs